ETANERCEPT TREATMENT RESULTS IN CHILDREN WITH NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: REMISSION, RECRUDESCENCE, AND ADVERSE EVENTS. RETROSPECTIVE COHORT STUDY

Background. Etanercept is a biological drug most commonly used in patients with juvenile idiopathic arthritis (JIA). The results of its use are showed in local studies.Objective. Our aim was to evaluate the efficacy and safety of the use of etanercept in children with non-systemic JIA, to determine...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Mikhail M. Kostik, Irina A. Chikova, Eugenia A. Isupova, Maria N. Likhacheva, Tatyana S. Likhacheva, Margaruta F. Dubko, Vera V. Masalova, Ludmila S. Snegireva, Ekaterina V. Gaidar, Olga V. Kalashnikova, Vyacheslav G. Chasnyk
Formáid: Artigo
Teanga:Inglês
Foilsithe: "Paediatrician" Publishers LLC 2018-05-01
Sraith:Voprosy Sovremennoj Pediatrii
Ábhair:
children
juvenile idiopathic arthritis
etanercept
remission
exacerbations
risk factors
Rochtain Ar Líne:https://vsp.spr-journal.ru/jour/article/view/1883
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla